Compare ETON & HYMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ETON | HYMC |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | United States |
| Employees | N/A | 51 |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 689.8M | 3.4B |
| IPO Year | 2018 | N/A |
| Metric | ETON | HYMC |
|---|---|---|
| Price | $30.61 | $33.37 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $39.33 | N/A |
| AVG Volume (30 Days) | 420.7K | ★ 1.9M |
| Earning Date | 05-14-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $79,950,000.00 | N/A |
| Revenue This Year | $40.90 | N/A |
| Revenue Next Year | $47.23 | N/A |
| P/E Ratio | $638.20 | ★ N/A |
| Revenue Growth | ★ 104.94 | N/A |
| 52 Week Low | $13.09 | $2.96 |
| 52 Week High | $35.66 | $58.73 |
| Indicator | ETON | HYMC |
|---|---|---|
| Relative Strength Index (RSI) | 53.53 | 42.78 |
| Support Level | $16.23 | $31.32 |
| Resistance Level | $32.31 | $46.05 |
| Average True Range (ATR) | 1.90 | 2.68 |
| MACD | -0.28 | -0.54 |
| Stochastic Oscillator | 35.51 | 15.76 |
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
Hycroft Mining Holding Corp is a United States-based gold and silver exploration-stage issuer. The company owns and is focused on developing its property, the Hycroft Mine, located northwest of Winnemucca, Nevada.